Evidence map›Paper›PMID 31337767›Full record

ArticleNature communications2019

RIF1 promotes replication fork protection and efficient restart to maintain genome stability.

Chirantani Mukherjee, Vivek Tripathi, Eleni Maria Manolika, Anne Margriet Heijink, Giulia Ricci, Sarra Merzouk, H Rudolf de Boer, Jeroen Demmers, Marcel A T M van Vugt, Arnab Ray Chaudhuri

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 123 citations in OpenAlex.

  1. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Repetitive Sequence Stability in Embryonic Stem Cells.International journal of molecular sciences · 2024
    Review
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Chirantani MukherjeeDepartment of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands.
Vivek TripathiDepartment of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands.
Eleni Maria ManolikaDepartment of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands.
Anne Margriet HeijinkDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Giulia RicciDepartment of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands.
Sarra MerzoukDepartment of Developmental Biology, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands.
H Rudolf de BoerDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-8386-8184
Jeroen DemmersDepartment of Biochemistry, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands.
Marcel A T M van VugtDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.
Arnab Ray ChaudhuriDepartment of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands. a.raychaudhuri@erasmusmc.nl.
Erasmus MC · NLUniversity Medical Center Groningen · NLMount Sinai Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homologous recombination (HR) and Fanconi Anemia (FA) pathway proteins in addition to their DNA repair functions, limit nuclease-mediated processing of stalled replication forks. However, the mechanism by which replication fork degradation results in genome instability is poorly understood. Here, we identify RIF1, a non-homologous end joining (NHEJ) factor, to be enriched at stalled replication forks. Rif1 knockout cells are proficient for recombination, but displayed degradation of reversed forks, which depends on DNA2 nuclease activity. Notably, RIF1-mediated protection of replication forks is independent of its function in NHEJ, but depends on its interaction with Protein Phosphatase 1. RIF1 deficiency delays fork restart and results in exposure of under-replicated DNA, which is the precursor of subsequent genomic instability. Our data implicate RIF1 to be an essential factor for replication fork protection, and uncover the mechanisms by which unprotected DNA replication forks can lead to genome instability in recombination-proficient conditions.

Indexed as

DNA ReplicationGenomic InstabilityAnimalsCells, CulturedDNA, CruciformMiceProtein DomainsProtein Phosphatase 1Telomere-Binding ProteinsDNA, CruciformProtein Phosphatase 1Rif1 protein, mouseTelomere-Binding Proteins

Identifiers

PMID31337767
PMCPMC6650494
OpenAlexW2964330526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.